De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Has Bob Iger now done it? Has he restored the magic, the thing defeated activist agitator Carl Icahn said was missing?
Charging infrastructure remains a barrier in EV adoption.
The company’s recent patent signals that AI is coming both for the world of advertising and entertainment at large.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Honeywell may just be the next conglomerate to split into various pieces. At least if Elliott Investment Management has its way.
A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a business.
Shell managed to overturn a Dutch legal order made in 2021 that had mandated the company cut its emissions 45% from 2019 levels by 2030.
Dissapointing results for two mid-stage trials strikes a blow in Abbvie’s expensive pipeline-via-M&A strategy.
Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.
Nintendo revealed on Tuesday that it had suffered a 69% drop in its profits year-over-year for the most recent financial quarter.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.